BiotechTube
Home/Protego Biopharma/Jeffrey W. Kelly, Ph.D.
JW

Jeffrey W. Kelly, Ph.D.

Board Member, SAB Chair, Co-Founder

Protego Biopharma

Therapeutic Areas

MyopathyCardiomyopathyStrokeRenal DiseaseRetinal DiseasesChannelopathiesDegenerative Diseases

Leadership Team at Protego Biopharma

BW
Brent Warner
Chief Executive Officer
MP
Mike Petrassi
Chief Scientific Officer
CW
Chris Weyrer, M.D., Ph.D.
Acting Chief Business Officer
RL
Richard Labaudinière, Ph.D.
Board Member, Former CEO, Co-Founder
View full Protego Biopharma profile